Enter a Ticker Symbol To Get Your Free Bull/Bear Rating & Ranking Report from "Stock Scientist" Mike Turner

Dividend Quote

NSPX

Inspyr Therapeutics Inc

Add to Scorecard

New Report from the Award-winning Analyst Who Beat the Market Over 15 Years

(For Privacy Policy visit us here)
*Note: You will not be spammed, ever. Period.

NSPX:Inspyr Therapeutics Inc - Stock Quote and Dividend Data

LATEST CLOSE PRICE

< $0.01

EXCHANGE

OTCBB

SECTOR

Health Care

NSPX
Inspyr Therapeutics Inc Dividend Information
Trailing 12 Month Dividend Yield0.00%
Projected 10 Year Dividend Yield0.00%
Dividend Yield 5 Year Average0.00%
Dividend Rate$0.00
Dividend Payout Ratio0.00%
Dividend Payout Ratio 5 yr Average0.00%
Dividend Growth Rate 3 yr Average0.00%
Dividend Growth Rate 5 yr Average0.00%
Dividend AllStar™ Ranking
Consecutive Dividend Increases0 Years

Dividend Payment TypeNone
Dividend Declaration DateNone
Dividend Ex DateNone
Dividend Record DateNone
Dividend Pay DateNone
Dividend Amount Current$0.000
Dividend Amount Previous$0.000
Dividends Paid in the Last 12 Months0
First Dividend PaidNone

FREE INVESTOR BRIEFING

Collect an 8% Yield on this "Government Mandated Income Opportunity"

(For Privacy Policy visit us here)
*Note: You will not be spammed, ever. Period.
NSPX
Inspyr Therapeutics Inc Stock Information
Latest Close Price< $0.01
52-Week Low/High$0.00 - $0.15
Percent Held by Institutions0.00%
Revenue$0
Net Income$-11,426,000
Cash Flow$0
EPS-0.69%
Market Cap$25,863
PE Ratio0
PE Ratio to Industry66%
Debt-Equity Ratio999,999.00%
Debt-Equity to Industry1.38%
Total Return Last 12 Months-93.25%
Total Return Last 3 Years-99.94%
Total Return Last 5 Years-99.99%
Latest Trade DateJan. 18, 2019
NSPX
Inspyr Therapeutics Inc Dividend Payment History

No Data available for Payment History.

NSPX
Inspyr Therapeutics Inc Other Details

Inspyr Therapeutics is an early-stage pharmaceutical company focused on the discovery and development of prodrug cancer therapeutics for the treatment of solid tumors, including brain, liver, prostate and other cancers. A prodrug is an inactive precursor of a drug that is converted into its active form only at the site of the tumor. Co.'s technology platform combines a cytotoxin with a patented prodrug delivery system that targets the release of the drug within the tumor. Co. has identified four prodrug candidates based on its technology: mipsagargin, which targets the blood vessels of most solid tumors; and G-115, G-114, and G-301, which target prostate cancer.

Web Sitewww.genspera.com
SectorHealth Care
SegmentPharmaceuticals & Biotechnology
IndustryPharmaceuticals
Dividend AllStar™ Ranking
Dividend Re-Investment PlanNo
Re-Investment AgentNone
Direct Purchase Minimum$0
Optional Cash Pay Min-Max$0 - $0
Optional Cash Payment FrequencyNone
Dividend Tools

Building a successful dividend income portfolio is simple… if you have the right tools at your disposal. Here’s a sampling of Dividend Investor’s Dividend Tools, used by thousands of investors across the globe to gain a substantial edge in their portfolio strategies.

Dividend AllStar™ Ranking

Find stocks with consecutively increasing dividends:

  • = 5 years of dividend increases
  • = 10 years of dividend increases
  • = 20 years of dividend increases

Click to Learn More

Monthly Dividend Directory

Learn which investments pay out every month, including:

  • Dividend yield
  • Ex-dividend date
  • Dividend payout date… and more

Click to Learn More

Stock Screening Tools

Screen and filter thousands of dividend-paying investments with Dividend Investor’s advanced screening tools:

  • Dividend Payout Ratio
  • Consecutive Increases
  • 5-Year Total Return… and more

Click to Learn More

Try Dividend Investor PREMIUM for as low as $29

  • Dividend Allstars™ Tool
  • Proprietary Ex-dividend Calendar
  • Dividend Scorecard™ Portfolio Tracker
  • Customized Dividend Stock Screener
  • 4 FREE special reports from leading dividend experts
  • And much more...
 
Inspyr Therapeutics Inc Dividend Stock News and Updates

Jan. 18, 2019CLOSE PRICE DECREASE: Inspyr Therapeutics Inc (OTCBB: NSPX) on 01-18-2019 decreased close price > 10% from $0.00 to $0.00

Read more...

Jan. 17, 2019CLOSE PRICE INCREASE: Inspyr Therapeutics Inc (OTCBB: NSPX) on 01-17-2019 increased close price > 10% from $0.00 to $0.00

Read more...

Jan. 16, 2019CLOSE PRICE DECREASE: Inspyr Therapeutics Inc (OTCBB: NSPX) on 01-16-2019 decreased close price > 10% from $0.00 to $0.00

Read more...
More Inspyr Therapeutics Inc Dividend News
Pharmaceuticals Dividend Stock News and Updates

Jan. 19, 2019CLOSE PRICE INCREASE: Acura Pharmaceuticals Inc (OTCBB: ACUR) on 01-19-2019 increased close price > 10% from $0.13 to $0.16

Read more...

Jan. 19, 2019CLOSE PRICE INCREASE: Aradigm Corp. (OTCBB: ARDM) on 01-19-2019 increased close price > 10% from $0.55 to $0.61

Read more...

Jan. 19, 2019CLOSE PRICE INCREASE: Burzynski Research Institute Inc (OTCBB: BZYR) on 01-19-2019 increased close price > 10% from $0.03 to $0.04

Read more...
More Pharmaceuticals Dividend News
X

Search Dividend Investor